Process and intermediates for the production of CCR2 antagonists

US9067951B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Heiner Ebel · Biberach an der Riß, DE
• Sara Frattini · Castelleone, IT
• Riccardo Giovannini · Verona, IT
• Christoph Hoenke · Ingelheim am Rhein, DE
• Thomas Trieselmann · Ochsenhausen, DE
• Patrick Tielmann · Bad Soden am Taunus, DE

Key dates

• Filing date: Jul 29, 2014
• Grant date: Jun 30, 2015
• Expiry date: Jul 29, 2034

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to a process for the production of novel antagonists for CCR2 (CC chemokine receptor 2) and intermediates thereof.